CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
63 hedge funds and large institutions have $118M invested in CTI BioPharma Corp. (DE) Common Stock in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
26% less capital invested
Capital invested by funds: $160M → $118M (-$41.3M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
63
Holding in Top 10
2
Calls
$1.07M
Puts
$570K
Top Buyers
| 1 | +$3.68M | |
| 2 | +$3.07M | |
| 3 | +$3.03M | |
| 4 |
BlackRock
New York
|
+$2.24M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.07M |
Top Sellers
| 1 | -$22.2M | |
| 2 | -$6.12M | |
| 3 | -$2.8M | |
| 4 |
Two Sigma Investments
New York
|
-$1.77M |
| 5 |
Two Sigma Advisers
New York
|
-$1.3M |